Financials

  • Market Capitalization 51.06 B
  • Employee 1 863
  • Founded 2008
  • CEO N/A
  • Website www.argenx.com
  • Headquarter Netherlands
  • FIGI BBG00GHB88X9
  • Industry 生物技术
总收入
净利润
总债务
自由现金流
现金及现金等价物

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
182
MRNA
Moderna, Inc. - Common Stock
225.00 USD+14.21%+17.49%+55.17%+725.69%89.83 B USD
218
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
746.54 USD+0.94%+1.66%-5.38%+35.24%76.86 B USD
367
RVMD
Revolution Medicines, Inc. - Common Stock
189.76 USD+0.87%-8.63%-6.75%+242.53%40.67 B USD
434
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
232.68 USD+3.63%+6.56%-6.99%-48.99%31.13 B USD

argenx SE - American Depositary Shares

Argenx SE 是一家专注于免疫学的比利时-荷兰制药公司。Argenx 专注于开发用于治疗自身免疫性疾病和癌症的抗体疗法。其工作主要侧重于孤儿药的研发。

新闻